Czechia – Antineoplastic and immunomodulating agents – LP pro autologní buněčnou terapii - ciltakabtagen autoleucel - 2026

The subject of the public contract is the supply of a medicinal preparation intended for the therapy of malignant blood diseases in a total expected volume of 30 individual doses of the medicinal preparation. The preparation is intended for the provision of healthcare at the healthcare facility FN Plzeň. The supplies of the subject of the contract will be realized on the basis of the results of the completed tender procedure for a period of three years from the signature of the purchase agreement.